Header

UZH-Logo

Maintenance Infos

Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)


Distler, Oliver; Brown, Kevin K; Distler, Jörg H W; Assassi, Shervin; Maher, Toby M; Cottin, Vincent; Varga, John; Coeck, Carl; Gahlemann, Martina; Sauter, Wiebke; Schmidt, Hendrik; Highland, Kristin B; SENSCIS™ trial investigators (2017). Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™). Clinical and Experimental Rheumatology, 35 Suppl(4):75-81.

Statistics

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:29 June 2017
Deposited On:11 Jul 2017 14:51
Last Modified:21 Nov 2017 19:35
Publisher:Pacini Editore SpA
ISSN:0392-856X
PubMed ID:28664834

Download

Full text not available from this repository.